nomegestrol acetate has been researched along with Venous Thromboembolism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauerfeind, A; Becker, K; DiBello, J; Franke, C; Heinemann, K; Koro, C; Reed, S | 1 |
| Mueck, AO; Sitruk-Ware, R | 1 |
1 review(s) available for nomegestrol acetate and Venous Thromboembolism
| Article | Year |
|---|---|
Nomegestrol acetate, a novel progestogen for oral contraception.
Topics: Contraceptives, Oral, Synthetic; Endometrium; Estrogens; Female; Humans; Megestrol; Norpregnadienes; Ovulation; Progesterone Congeners; Receptors, Steroid; Venous Thromboembolism | 2011 |
1 other study(ies) available for nomegestrol acetate and Venous Thromboembolism
| Article | Year |
|---|---|
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
Topics: Adult; Cohort Studies; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Megestrol; Norpregnadienes; Prospective Studies; Venous Thromboembolism; Young Adult | 2021 |